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ALG11-CDG
Burst suppression EEG
Neuronal heterotopiaWereport on two novel patients with ALG11-CDG. The phenotypewas characterized by severe psychomotor dis-
ability, progressive microcephaly, sensorineural hearing loss, therapy-resistant epilepsy with burst suppression
EEG, cerebral atrophy with, in one of them, neuronal heterotopia, and early lethality. Analysis of ALG11 revealed
compound heterozygosity involving three novel mutations: the splice site mutation c.45-2A N T, the c.36dupG
duplication, and the missense mutation c.479G N T (p.G160V) that was present in both.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
N-linked glycosylation is an important posttranslational modiﬁ-
cation of proteins. N-linked glycans are assembled in the endoplas-
mic reticulum (ER) and subsequently remodeled in the ER and the
Golgi apparatus. The assembly of N-glycans starts at the cytosolic
side of the ER with the addition of GlcNAc monophosphate to the
lipid carrier dolichol phosphate (Dol-P) and leads to the formation
of a 14 monosaccharides-containing dolichol-linked oligosaccharide
(DLO), Dol-PP-GlcNAc2Man9Glc3. At the cytosolic side of the ER the
intermediate DLO, Dol-PP-GlcNAc2Man5, is formed and then ﬂipped
by support of the RFT1 protein to the luminal side of the ER where
the assembly is completed. Genetic defects in the N-glycan assembly
belong to the large family of congenital disorders of glycosylation
(CDG) (review in [1]). Recently, ﬁve patients (from four families)
have been reported with ALG11-CDG [2,3]. ALG11 encodes the
mannosyltransferase that adds the fourth and the ﬁfth of the nine
mannoses in the completed DLO. We report on two novel patients.
The characterization of their disease broadens the clinical and muta-
tional spectrum of ALG11-CDG.Diseases, University Hospital
n).
. This is an open access article under2. Patients
2.1. Patient 1
He was born as the ﬁrst child of unrelated, Belgian parents at a ges-
tational age of 37.5weeks. At birthweightwas 2360 g, length 46 cmand
head circumference 30 cm. He had micrognathia, a sloping forehead
with a salmonpatch, absentmidpalmar creases, thick feet and anumbil-
ical hernia. He had polypneawith inspiratory stridor. Therewas striking
axial hypotonia with absent head control during pull-to-sit, only brief
head elevation lying prone, and slipping through in axillary suspension,
even at the age of 13 months. Peripheral tone was increased, as were
tendon reﬂexes. Moro reﬂexwas absent and glabella reﬂexwas normal.
Plantar reﬂexes were extensor, with trembling of the lateral toes. He
had little spontaneous movements. At 18 months, he did not follow
with the eyes, and there was no consistent eye contact. Ophthalmologic
evaluation showed papillary atrophy and retinal dystrophy with low
amplitudes on ﬂash ERG. Because of severe sensorineural hearing loss
(no response at 80 dB), he received hearing aids. From the ﬁrst week
there were frequent epileptic seizures each day, at ﬁrst with elevation
and extension of the arms, elevation of the eyes and followed by crying,
later in the course of the illness evolving to lateralized clonic move-
ments with the head and left arm, lasting several minutes. EEG showed
a burst suppression pattern, which persisted despite treatment with
phenobarbitone, valproic acid, levetiracetam and vigabatrin. After the
introduction of topiramate, improvement in seizure frequency andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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esophageal reﬂux, which responded to conservative treatment. An in-
carcerated inguinal hernia was surgically corrected at age 5 months.
The fontanel was nearly closed at that time. Absolute and relative mi-
crocephaly was progressive, with a standard deviation score (SDS) of
— 6.7 for head circumference, SDS for length being— 2.4 and for weight
— 2.7 at 18 months.
Biochemical investigation showed a normal blood count, and normal
levels of blood lactate and serum albumin, cholesterol, transaminases,
creatine kinase, lactate dehydrogenase, amino acids, arylsulphatase A,
thyroid stimulating hormone, total T4, thyroxine binding globulin and
prolactin. Blood coagulation factor XI (27%; normal range for age:
38–164%), and protein C (25%; normal range for age: 37–81%) were
decreased. Capillary zone electrophoresis of serum transferrin revealed
a type 1 pattern.
Ultrasonography of heart, liver, spleen and kidneys was normal.
Radiology of the skeleton revealed amildly broadened aspect of the dis-
tal metaphysis of the long bones of the limbs. Brainmagnetic resonance
imaging (MRI) showed symmetrical anteriorly predominant subcortical
heterotopias and a simpliﬁed gyral pattern. Repeated MRI at the age of
1 year revealed a striking atrophy of white matter and cortex and sec-
ondary dilatation of the ventricles, with relative sparing of cerebellum
and brainstem. Myelination was severely retarded (Fig. 1). Epilepsy
was never satisfactory controlled. He died at the age of 3 1.5/12 years
from respiratory insufﬁciency due to a pulmonary infection.
Analysis of dolichol-linked oligosaccharides in patient-derived
ﬁbroblasts (according to Rind et al. [2]) revealed an accumulation
of Man3GlcNAc2-PP-Dol and Man4GlcNAc2-PP-Dol, the substrates of
ALG11. These compounds are normally undetectable.
Genetic testing showed two variants in ALG11: c.479G N T (p.G160V)
and the splice site variant c.45-2A N T. The parents are carriers of these
variants.
2.2. Patient 2
This boywas admitted at the age of 3monthswith feeding problems
and failure to thrive. He was the ﬁrst child of unrelated, Dutch parents
and born after a full term uncomplicated pregnancy. Neonatal hearing
examination had revealed cochlear hearing loss for which he received
hearing aids. During the ﬁrst month of life he was otherwise doing
well. He made eye contact and was ﬁxating objects. After the ﬁrst
month, he started to cry inconsolably in between feeds. His parents
noted the loss of eye contact. Progressive microcephaly was noted
with SDS for head circumference decreasing from −2 SDS at one
month to−3.2 SDS at 4 months of age. There were no dysmorphic fea-
tures. The boy was awake and showed wandering eye movements.
There was no visual reaction on light. He showed axial hypotonia and
peripheral hypertonia. Reﬂexes were brisk. Tonic seizures were seen
with opening of the eyes and freezing, as well as infantile spasms.
EEG showed an abnormal background with high amplitude, bursts
of spikes and waves and periods of suppression consistent with epilep-
tic encephalopathy. Brain MRI at 3.5 months showed frontally a largeA B C
Fig. 1. A–D: Axial T2-weighted (A, B) and sagittal T1-weighted (C, D) cerebral MRI in patien
heterotopias (A), a simpliﬁed gyral pattern (A, C), and severe progressive cerebral atrophy andextracerebral ﬂuid collection probably due to cerebral atrophy. Oph-
thalmological examination was normal except for a mild intermittent
esotropia. On follow-up examination hearing loss had worsened
(70–90 dB loss) with the involvement of the cochlea as well as the
nerve and the brainstem. Biochemical investigation showed a slight in-
crease of serum creatine kinase (218 U/L, nl b 170 U/L), an increased
lactate (3.6, 3.9 mmol/L), slightly decreased copper (0.53, nl N 0.70
mg/L) and ceruloplasmin (0.10, nl N 0.20 g/L) levels, normal plasma
aminoacids (except for an elevated threonine), acylcarnitine proﬁle,
very long chain fatty acids, phytanic acid, pristanic acid, chitotriosidase
activity, antithrombin, protein C and factor XI, and normal urinary
analysis of organic acids, amino acids, purines and pyrimidines, glycos-
aminoglycans, polyols and sialic acid. Cerebral spinal ﬂuid showed nor-
mal glucose, lactate, neurotransmitters, amino acids and pipecolic acid.
Capillary zone electrophoresis of serum transferrin repeatedly showed
a type 1 pattern. The treatment for epileptic seizures was started with
ACTH and pyridoxal phosphate. Vigabatrin was added because of
increasing seizure frequency. Continuous intravenous midazolam and
phenobarbital were added because of ongoing seizures, followed by
propofol infusion, without signiﬁcant effect on seizure activity. In spite
of adequate blood levels of anti-epileptic drugs, seizures continued
and were associated with respiratory distress. The refractory epilepsy
resulted in respiratory insufﬁciency. Because of the poor prognosis fur-
ther intensive care treatment was discontinued. He died at 4 months
due to respiratory insufﬁciency secondary to epilepsy.
Genetic testing showed two variants in ALG11: c.479G N T (p.G160V)
and c.36dupG. The parents are carriers of these variants.
3. Discussion
The type 1 serum sialotransferrin pattern in these patients pointed
to a defect in the N-glycan assembly pathway. The result of the
dolichol-linked analysis in ﬁbroblasts of patient 1 strongly suggested a
defect in ALG11. Mutation analysis of ALG11 showed compound hetero-
zygosity in both patients. Three novel variants were found. Two of these
variants are certainly deleterious: c.36dupG causes a frame shift for
translation; c.45-2A N T hits a consensus splice site. Onemissensemuta-
tion was shared by both patients. The following arguments are in favor
of the pathogenicity of p.G160V: i. glycine at position 160 is strongly
conserved among species; ii. this variant was not found in the 1000G
(www.1000genomes.org), Genome of the Netherlands (GoNL; www.
nlgenome.nl) or Exome Variant Server (http://evs.gs.washington.edu/
EVS/) databases; and iii. the programs SIFT and POLYPHEN predict a
pathogenic effect.
Five patients have been described with ALG11-CDG [2,3]. Table 1
summarizes the clinical ﬁndings of the reported and of our patients.
Common to all seven patients are an important psychomotor disability,
severe epilepsy (including infantile spasms in one), and axial hypotonia.
The following symptomswere present in amajority of patients: feeding
problems (4/7), microcephaly (3/5), deafness (4/7), poor eye contact
(4/6), and peripheral hypertonia (4/7). A minority of patients showed
convergent strabism, oscillations of body temperature, ataxia, variousD
t 1 at 1 month (A, C) and at 1 year (B, D), showing anteriorly predominant subcortical
delay in myelination at 1 year (B, D).
Table 1
Summary of clinical features and mutations in ALG11-CDG patients.
Rind et al. 2010 (pt A) Rind et al. 2010 (pt B) Thiel et al. 2012 (pt A) Thiel et al. 2012 (pt B) Thiel et al. 2012 (pt C) Present report (pt 1) Present report (pt 2)
Age Died at 2 years NA 7 years at publication 4.5 years at publication 8.5 years at publication Died at 3 years Died at 4 months
Gender Female Male Female Female Male Male Male
Ethnic origin Turkish Turkish French–Canadian Caucasian Turkish Belgian Dutch
Microcephaly + NA + NA − + +
Psychomotor
disability
+ + + + + + +
Hypotonia Axial + Axial Axial Axial Axial Axial
Hypertonia − − Peripheral Peripheral − Peripheral Peripheral
Hyperreﬂexia NA NA NA NA NA + +
Epilepsy + + + + + + +
Deafness + + Not mentioned Not mentioned Not mentioned + +
Eye/visual problems Poor visual tracking NA Strabismus convergens No visual tracking, strabismus
convergens
Strabismus
convergens
No consistent eye contact,
papillary atrophy and retinal
dystrophy
Loss of eye contact
Feeding problems + + − − + + −
Dysmorphism Fat pads, inverted nipples − − Plagiocephaly, nasal anteversion,
long ﬁltrum, mild retrognathia, fat
pads, inverted nipples, poorly
developed teeth, scoliosis,
bilateral hip dislocation,
− Sloping forehead with salmon
patch, micrognathia, absent
midpalmar creases, umbilical
hernia, thick feet
−
Other features Oscillations of body
temperature
NA Cerebral atrophy and
abnormal white matter
Oscillations of body temperature Atactic movement
disorder
Hypokinesia, burst suppression
pattern on EEG, atrophy of white
matter and cortex, subcortical
heterotopia, retarded myelination
Burst suppression pattern
on EEG, cerebral atrophy
Mutation(s):
cDNA/protein
Homozygous
c.T257C/p.L86S
Homozygous
c.T257C/p.L86S
c.623_642del/frame shift;
c836A N C/p.Y279S
c.1142 T N C/p.L381S;
c.1192G N A/p.E398K
Homozygous
c.953A N C/p.Q318P
c.479G N T/p.G160V; c.45-2A N T c.479G N T/p.G160V;
c.36dupG
NA: not available.
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phy and white matter abnormalities. Our patients as well as the ﬁrst
patient of Rind et al. [2] died at an early age. Novel ALG11-CDG features
in our patients were a burst suppression pattern on EEG (in both), and
subcortical heterotopias in one. In the previously reported siblings
with ALG11-CDG, generalized epileptic activity on EEG is described
without further details. A burst suppression EEG pattern has to our
knowledge not been reported in CDG. While the epilepsy was clearly
therapy-resistant, therapy with topiramate appeared to be beneﬁcial.
Also, heterotopia is not known as a feature of CDG-I. Follow-up cerebral
MRI at the age of 1 year in patient 1 revealed rapidly progressive
cerebral atrophy, explaining the progressive microcephaly and the
poor developmental outcome in this patient. Microcephaly was also
progressive in patient 2. Comparable progressive atrophy has been re-
ported inmitochondrial disorders, but seems not to have been reported
in CDG. Sensorineural deafness was a prominent feature in four of the
seven ALG11-CDG patients. Sensorineural deafness is highly unusual
in other types of CDG, except RFT1-CDG [4,5]. Interestingly, RFT1 is
responsible for the translocation of the DLO Dol-PP-Man5GlcNAc2from the cytosolic side of the ERmembrane to its luminal side. This pro-
vides support for the hypothesis that the cytoplasmic accumulation of
one or more of the substrates of ALG11 and RFT1 has an otoneurotoxic
effect [5], ormaybe an evenmore general deleterious effect on thebrain.
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